PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 9, 2018EP Europace231 citationsOpen Access

Antiarrhythmic drugs–clinical use and clinical decision making: a consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and International Society of Cardiovascular Pharmacotherapy (ISCP)

View Full Paper
GDGheorghe‐Andrei DanAMAntoni Martínez‐RubioSAStefan Agewall

Key Points

Key points are not available for this paper at this time.

Abstract

fibrillation VPB Ventricular premature beats VT Ventricular tachycardia WPW Wolff-Parkinson-White

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Dan et al. (2018) studied this question. Antiarrhythmic drug clinical use and decision-making for managing fibrillation, ventricular tachycardia, and Wolff-Parkinson-White syndrome are detailed in this expert consensus document.

synapsesocial.com/papers/6aa3730222af0bded4f423f7https://doi.org/10.1093/europace/eux373
Ask AI
Helpful
Bookmark
Share
View Full Paper